Citadel Advisors
FBIO icon

Citadel Advisors’s Fortress Biotech FBIO Stock Holding History

Citadel Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.2K Sell
29,100
-31,800
-52% -$108K ﹤0.01% 12162
2025
Q4 		$223K Buy
+60,900
New +$174K ﹤0.01% 10802
2025
Q2 		– Sell
-66,900
Closed -$104K – 13253
2025
Q1 		$104K Sell
66,900
-12,500
-16% -$22K ﹤0.01% 11393
2024
Q4 		$161K Buy
79,400
+71,700
+931% +$130K ﹤0.01% 10780
2024
Q3 		$11.1K Buy
7,700
+4,600
+148% +$8.76K ﹤0.01% 13169
2024
Q2 		$5.3K Sell
3,100
-6,600
-68% -$12K ﹤0.01% 13412
2024
Q1 		$19.4K Sell
9,700
-5,300
-35% -$10.5K ﹤0.01% 13036
2023
Q4 		$45.1K Buy
15,000
+14,847
+9,704% +$39.3K ﹤0.01% 11888
2023
Q3 		$668 Sell
153
-87
-36% -$597 ﹤0.01% 14007
2023
Q2 		$1.98K Buy
240
+53
+28% +$524 ﹤0.01% 13847
2023
Q1 		$2.3K Buy
+187
New +$2.23K ﹤0.01% 14171
2022
Q3 		– Sell
-1,307
Closed -$16K – 12893
2022
Q2 		$16K Sell
1,307
-4,153
-76% -$61.5K ﹤0.01% 12477
2022
Q1 		$111K Sell
5,460
-120
-2% -$3.29K ﹤0.01% 12173
2021
Q4 		$209K Buy
5,580
+467
+9% +$20.8K ﹤0.01% 11759
2021
Q3 		$247K Buy
5,113
+626
+14% +$30.6K ﹤0.01% 11504
2021
Q2 		$240K Buy
+4,487
New +$271K ﹤0.01% 11779
2015
Q4 		– Sell
-320
Closed -$12K – 8837
2015
Q3 		$12K Sell
320
-113
-26% -$5.28K ﹤0.01% 8401
2015
Q2 		$22K Sell
433
-134
-24% -$6.88K ﹤0.01% 8103
2015
Q1 		$33K Buy
+567
New +$23.6K ﹤0.01% 7635
2014
Q3 		– Sell
-340
Closed -$9K – 8193
2014
Q2 		$9K Sell
340
-80
-19% -$2.11K ﹤0.01% 7599
2014
Q1 		$12K Sell
420
-7
-2% -$273 ﹤0.01% 7459
2013
Q4 		$17K Buy
+427
New +$16.5K ﹤0.01% 6549

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's FBIO Position: Q1 2026 in Review

Citadel Advisors opened a new position in Fortress Biotech (FBIO) in Q1 2026: 180,289 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #9293 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in FBIO as recently as Q2 2025.

Citadel Advisors first reported a position in FBIO in Q3 2013 and has held it in 25 quarters since. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Citadel Advisors held 180,289 shares of Fortress Biotech worth $503K as of Q1 2026.
  • Fortress Biotech was a new Citadel Advisors position in Q1 2026.
  • Fortress Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9293 holding.
  • Citadel Advisors first reported a position in Fortress Biotech in Q3 2013 and has held it in 25 quarters since.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.